Warrant To Purchase Common StockSecurity Agreement • July 10th, 2017 • Opgen Inc • Services-medical laboratories • New York
OpGen, Inc., a company organized under the laws of Delaware (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, ___________________________, the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Initial Exercisability Date (as defined below), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), ___________________ fully paid non-assessable shares of Common Stock, par value $0.01 per share, subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in thi
AMENDED & RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • July 10th, 2017 • Opgen Inc • Services-medical laboratories • Delaware
THIS AMENDED & RESTATED NOTE PURCHASE AGREEMENT, is made as of July 10, 2017 (this “Agreement”), by and among OpGen, Inc., a Delaware corporation (the “Company”), and jVen Capital, LLC, a Delaware limited liability company (the “Investor”). Certain capitalized terms used in this Agreement are set forth in Section 1.4.
